Sarthak Metals Limited — PPTs, 14-08-2025: Investor Presentation

**1. Financial Highlights:**

Q1 FY26 revenue reached ₹46.22 Cr (+14% YoY, -4% QoQ). PAT was ₹1.06 Cr (-24% YoY, +58% QoQ), with EBITDA margin at 3.80%. Cored wires generated ₹35 Cr revenue (+39% YoY volume). Aluminium Flipping Coil (₹7 Cr) operations were scaled down due to margin pressures.

**2. Strategic Initiatives & Growth Drivers:**

Sarthak is diversifying into cored wire, welding, and biotechnology. Welding aims for ₹25 Cr annual sales, leveraging RDSO approval. Biotech's 14 kg Solid State Fermentation (SSF) pilot facility is operational, planning a large-scale expansion.

**3. Business Developments:**

Welding division revenue hit ₹2.7 Cr in Q1 FY26 (+17% QoQ volumes), boosted by RDSO approval for Indian Railways. Biotech's SSF pilot production commenced.

**4. Market Position & Competitive Advantage:**

Cored wires' technological edge pushed capacity utilization over 50%. Welding targets import substitution, gaining an advantage with RDSO approval. Biotech explores high-demand industrial enzymes.

**5. Investor Implications:**

Strategic diversification in welding and biotechnology offers positive growth potential. While the aluminum segment's scaled-down operations need monitoring, the company's focus on resilience and long-term success targets sustainable value.